AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Traws Pharma, Inc. Director's Dealing 2025

Jun 23, 2025

Director's Dealing

Opens in your device viewer

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2025-06-19

Reporting Person: CAUTREELS WERNER (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-19	Stock Option (right to purchase)	$1.65	A	23000	Acquired	2035-06-19	Common Stock (23000)	Direct

F1: These options vest 100% on the first anniversary of the grant date.